Adagio Medical Holdings, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Adagio Medical Holdings, Inc. (ADGM) on April 17, 2025. The Company is incorporated in Delaware and trades on The Nasdaq Stock Market LLC. The report discloses a material change in executive leadership regarding the appointment of an Interim Chief Financial Officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel changes and does not contain financial performance data.
Material Changes
- Executive Appointment: On April 17, 2025, the Company appointed Daniel George as Interim Chief Financial Officer.
- Designations: Mr. George is designated as the Company's principal financial officer and principal accounting officer.
- Compensation: Mr. George will be compensated at a rate of $400 per hour under an "at will" employment basis.
- Background: Mr. George brings extensive experience in healthcare finance, having previously served as CFO for Lucira Health, Inc., Avinger Inc., and Avantis Medical Systems, Inc.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, outlook, management commentary on financial performance, or specific risk factors. The document notes that the full text of the Offer Letter will be filed as an exhibit to the Quarterly Report on Form 10-Q for the three months ended March 31, 2025.
Investor Verification Checklist
- Verify the full terms of the Offer Letter for Daniel George in the upcoming Form 10-Q filing.
- Confirm the departure details of the previous Chief Financial Officer, if applicable, to understand the transition context.
- Review the upcoming Form 10-Q for the quarter ended March 31, 2025, for actual financial performance metrics.
- Monitor for any subsequent filings regarding the permanent appointment of a CFO.